About this trial
The study aims to compare the modified approach through ipsilateral deep calf venous access or contralateral femoral venous access with the traditional approach through ipsilateral popliteal venous access for iliofemoral deep venous thrombosis (DVT) with distal popliteal vein thrombosis, and determine whether it can achieve similar therapeutic effects as iliofemoral DVT without distal popliteal vein thrombosis.
Eligibility criteria
Qualifiers
Age between 18-85 years old;
Acute DVT occurred no more than 14 days since the onset of disease;
DVT treated by percutaneous mechanical thrombectomy
Informed consent signed by patients.
Disqualifiers
Patients who are known to be allergic to heparin, low molecular weight heparin, or contrast agent;
Women during pregnancy and lactation;
Patients with other diseases that may cause difficulty in the study or significantly shorten the life expectancy of patients (<6 months);
Patients who are unable or unwilling to participate in the study.
Trial design
Treatments tested in this trial
- Percutaneous mechanical thrombectomy (PMT) by the modified approach
- Percutaneous mechanical thrombectomy (PMT) by the traditional approach
- Traditional approach
Treatment groups
Sponsors and collaborators
RenJi Hospital
Lead sponsor
First People's Hospital of Hangzhou
Collaborator
Chengdu University of Traditional Chinese Medicine
Collaborator